Key Updates
On Holding AG declined 2.06% to $44.12, extending the correction pattern identified in previous reports and breaking below the $45 support level that had held since mid-January. The stock now trades 5.08% below its 2026 opening level, with accelerating downside momentum evident across all timeframes (9.79% decline over 5 days, 9.16% over 1 month). Despite this technical weakness, The Guardian article from January 11th confirms robust operational momentum with sales projected to increase over 33% to CHF 3 billion in 2026 and the company maintaining its $16 billion market valuation, creating a notable disconnect between price action and fundamental performance.
Current Trend
On Holding is in a clear downtrend across all measured timeframes. The YTD decline of 5.08% has accelerated through January, with the stock losing 9.79% over the past five trading days. The breach of the $45 support level represents a technical breakdown from the consolidation range that characterized early January trading. The 16.94% decline over six months indicates broader distribution pressure, though the current $44.12 level may represent a near-term oversold condition given the velocity of recent declines. Resistance now firmly established at $45-$47, with the stock requiring significant catalyst to reclaim these levels.
Investment Thesis
On Holding represents a high-growth premium athletic footwear company executing aggressive market share capture in the $450 billion global sportswear market. The company has achieved approximately 20% market share in UK and European running shoe segments despite controlling only 1% globally, indicating substantial runway for expansion. The investment thesis centers on three pillars: technological differentiation through innovations like LightSpray robot-manufactured shoes, premium pricing power (£120-£495 per pair) that sustains margins, and strategic retail expansion with 25 new stores planned annually from a current base of 60 locations. With projected 2026 sales of CHF 3 billion representing 33%+ growth and a target of 30 million pairs sold, On demonstrates scalable unit economics while maintaining its $16 billion valuation despite recent price weakness.
Thesis Status
The investment thesis remains intact from a fundamental perspective but faces mounting technical pressure. The disconnect between operational execution and stock performance has widened significantly since the January 17th report. Confirmed sales growth of 33%+ and maintenance of the $16 billion market valuation validate the growth narrative, yet the stock has declined 9.79% over five days. This suggests either broader market de-risking from premium valuations, sector rotation away from athletic apparel, or profit-taking following the company's doubling in value since its 2021 IPO at $8 billion. The thesis requires monitoring for any fundamental deterioration, but current evidence points to technical rather than business-model concerns.
Key Drivers
On's market expansion strategy continues to drive growth, with the company capturing 20% market share in key European running shoe markets while competing against Nike (14% global share) and Adidas (9% global share) from a 1% base. The 30 million pairs sales target for 2026 represents significant volume growth, supported by retail expansion of 25 stores annually and development of automated manufacturing facilities closer to key markets. The premium positioning (£120-£495 price range) provides margin protection while the LightSpray technology offers product differentiation. However, the technical breakdown suggests investors may be reassessing valuation multiples or anticipating near-term headwinds not yet reflected in company guidance.
Technical Analysis
On Holding has broken critical support at $45.00, a level that had contained declines since the January 15th rebound. The current $44.12 price represents a 16.94% decline from six-month highs and establishes a lower low in the developing downtrend. Volume characteristics during the 9.79% five-day decline suggest distribution rather than capitulation, indicating potential for further downside testing. Immediate support exists at $43.50-$44.00, with more substantial support in the $40-$42 range based on the six-month decline trajectory. Resistance has solidified at $45.00 (former support), $47.00 (previous consolidation level), and $48.50 (one-month high). The stock requires stabilization above $45.00 to invalidate the breakdown pattern. Momentum indicators point to oversold conditions on shorter timeframes, but the intermediate-term trend remains firmly negative until price structure improves.
Bull Case
- Exceptional revenue growth trajectory with sales projected to increase over 33% to CHF 3 billion in 2026, demonstrating scalable business model execution and strong demand for premium athletic footwear products across expanding geographic markets.
- Dominant 20% market share capture in UK and European running shoe segments validates product-market fit and brand strength, providing blueprint for replication in underpenetrated markets where On currently holds minimal presence.
- Premium pricing power with shoes ranging £120-£495 enables superior margin structure compared to mass-market competitors, protecting profitability while funding innovation and retail expansion investments.
- Technological differentiation through LightSpray robot-manufactured shoes and automated manufacturing facilities creates sustainable competitive advantages and positions On to reduce production costs while maintaining quality standards.
- Strategic retail expansion of 25 new stores annually from current 60-store base provides direct consumer relationships and brand control while the 1% global market share leaves substantial runway for penetration in the $450 billion sportswear market.
Bear Case
- Minimal 1% share of the $450 billion global sportswear market exposes On to intense competition from Nike (14% share) and Adidas (9% share), which possess vastly superior scale, distribution networks, and marketing resources to defend market position.
- Accelerating technical breakdown with 16.94% decline over six months and breach of $45 support level indicates institutional distribution and potential valuation compression, particularly concerning given the stock's doubling from $8 billion IPO valuation to $16 billion current market cap.
- Premium pricing strategy (£120-£495 per pair) limits addressable market during potential economic slowdown and makes On vulnerable to consumer trading down to lower-priced alternatives from established competitors.
- Aggressive retail expansion of 25 stores annually and automated manufacturing facility investments require substantial capital deployment with execution risk, potentially pressuring near-term cash flows and margins during buildout phase.
- Concentrated momentum in 5-day (9.79% decline) and 1-month (9.16% decline) timeframes suggests deteriorating investor sentiment that may not yet reflect in fundamental guidance, raising concerns about forward visibility or undisclosed operational challenges.